Ispecimen releases cancer biospecimen offering; orders anticipated of over $9,500,000 annually

Woburn, mass., nov. 07, 2024 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today a significant enhancement to its searchable inventory that provides researchers with increased access to a wide array of biospecimens vital to advancing oncology research and treatments.
ISPC Ratings Summary
ISPC Quant Ranking